Future Science Group
Share
FSG is a progressive publisher focused on breakthrough medical and biotechnological research. Both publish eBooks and journals.
Founded in 2001, Future Science Group’s portfolio consists of two imprints, Future Science and Future Medicine. In addition to this core publishing business, Future Science Group develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Pharmacogenomics and the award-winning Regenerative Medicine. The aim of Future Science Group is to serve the advancement of clinical practi
🚨 Important Announcement: Future Science Group Joins Taylor and Francis! 🚨
We are pleased to announce that Future Science Group has been acquired by Taylor and Francis.
As part of this transition, our LinkedIn page will be closing on the 29th March 2024. However, you can continue to stay informed and engaged by following updates via &FrancisGroup.
We want to take this opportunity to express our heartfelt gratitude for your continued support. Your engagement and participation have been invaluable to us, and we look forward to continuing this journey together under the Taylor and Francis umbrella.
Thank you for being part of our community!
04/12/2023
Biomedical publisher Future Science Group joins Taylor & Francis Taylor & Francis now becomes the fourth largest publisher of pharma-funded research, with the addition of 32 peer-reviewed FSG journals and five digital hubs.
29/09/2023
We are pleased to announce the launch of Future Medicine AI, a new open access, peer-reviewed journal committed to advancing the application of artificial intelligence (AI) in medicine.
As AI reshapes medicine, Future Medicine AI will be positioned uniquely as a central hub for the communication and dissemination of the latest practice-changing research and high-quality industry insights.
Read more here: https://bit.ly/46uN1fu
05/04/2023
We are excited to announce the launch of Future Medicine AI Hub, a new digital site, committed to advancing the application of in medicine.
The portal, which is free to registered users, features breaking news, peer-reviewed content from FSG journals, interviews with key opinion leaders, and other site-exclusive features. Join today!
https://bit.ly/40JRdW2
23/01/2023
Interested in discussing at ? FutureScienceGroup leads the way, having published over 60 standalone plain language summaries of publications with 130,000+ downloads – visit us at booth M to find out more
20/01/2023
Come and find out how Future Science Group is fuelling creativity in medical publishing
19/01/2023
Attending ? Swing by booth M to meet the team, to discuss our innovative products for 2023
18/01/2023
Looking to increase the impact and accessibility of your research? Visit us at where we can discuss our digital omnichannel solutions
09/09/2022
We are greatly saddened to hear the news that Her Majesty, Queen Elizabeth II has passed away. Our thoughts are with the Royal Family at this time.
Photo from The Royal Family
22/07/2022
Our latest plain language summary provides an overview of a study looking at the investigational drug iclepertin for the treatment of cognitive symptoms in people with schizophrenia.
Using non-technical language and images, the article can help patients and their caregivers as well as patient advocates and healthcare professionals learn more about the study.
Read the article here:
📖 – https://bit.ly/3Pltwhb
Click here to claim your Sponsored Listing.
Category
Contact the business
Address
Unitec House , 2 Albert Place
London
N31QB
Opening Hours
| Monday | 8:30am - 6:30pm |
| Tuesday | 8:30am - 6:30pm |
| Wednesday | 8:30am - 6:30pm |
| Thursday | 8:30am - 6:30pm |
| Friday | 8:30am - 6:30pm |